NASDAQ: CGNTCognyte Software Ltd Stock
$6.64+0.22 (+3.43%)
Updated Apr 22, 2024
CGNT Price
$6.64
Fair Value Price
$1.47
Market Cap
$471.42M
52 Week Low
$4.00
52 Week High
$8.53
P/E
-30.18x
P/B
2.38x
P/S
1.58x
PEG
N/A
Dividend Yield
N/A
Revenue
$313.40M
Earnings
-$15.57M
Gross Margin
68.7%
Operating Margin
-5.48%
Profit Margin
-5%
Debt to Equity
1.3
Operating Cash Flow
$35M
Beta
1.24
Next Earnings
Jun 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A
CGNT Overview
Cognyte Software Ltd. provides investigative analytics software to over 1,000 government and enterprise customers in the U.S. and internationally. The company's software enables its cusomters to identify, neutralize, and prevent threats to national security, business continuity, and cyber security. Cognyte Software was incorporated in 2020 and is headquartered in Herzliya, Israel.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CGNT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CGNT ($6.64) is overvalued by 352.35% relative to our estimate of its Fair Value price of $1.47 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CGNT ($6.64) is not significantly undervalued (352.35%) relative to our estimate of its Fair Value price of $1.47 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CGNT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CGNT due diligence checks available for Premium users.
Be the first to know about important CGNT news, forecast changes, insider trades & much more!
CGNT News
Valuation
CGNT fair value
Fair Value of CGNT stock based on Discounted Cash Flow (DCF)
Price
$6.64
Fair Value
$1.47
Overvalued by
352.35%
CGNT ($6.64) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CGNT ($6.64) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CGNT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CGNT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-30.18x
Industry
75.11x
Market
41x
CGNT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.38x
Industry
11.55x
CGNT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CGNT's financial health
Profit margin
Revenue
$83.7M
Net Income
-$2.6M
Profit Margin
-3.1%
CGNT's Earnings (EBIT) of -$17.17M... subscribe to Premium to read more.
Interest Coverage Financials
CGNT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$472.1M
Liabilities
$257.3M
Debt to equity
1.3
CGNT's short-term assets ($264.98M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CGNT's short-term assets ($264.98M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CGNT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CGNT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$9.8M
Investing
$18.9M
Financing
-$2.5M
CGNT's operating cash flow ($34.56M)... subscribe to Premium to read more.
Debt Coverage Financials
CGNT vs Software Infrastructure Stocks
Cognyte Software Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.